Among the underlying causes, mineral metabolism alterations have been implicated, including derangement of calcium-phosphate homeostasis [7], which leads to secondary hyperparathyroidism (sHPT) characterized by elevated parathyroid hormone (PTH) levels and parathyroid hyperplasia [8,9,10,11,12]. The gene discussed is PTH; the disease is parathyroid hyperplasia.